# Bella Kaufman

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/bella-kaufman/

## Facts

| Field | Value |
| --- | --- |
| Citations | 38,732 |
| Field | BRCA gene mutations in cancer |
| h-index | 80 |
| i10-index | 206 |
| Last Known Institution | NYU Langone Health |
| OpenAlex ID | https://openalex.org/A5050390557 |
| ORCID iD | https://orcid.org/0000-0002-4236-3374 |
| Works | 427 |

## Researcher papers

- [The human tumor microbiome is composed of tumor type–specific intracellular bacteria](https://scholariq.org/papers/the-human-tumor-microbiome-is-composed-of-tumor-type-specific-intracellular/)
- [3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)](https://scholariq.org/papers/3rd-eso-esmo-international-consensus-guidelines-for-advanced-breast-cancer-abc-3/)
- [Adjuvant Olaparib for Patients with <i>BRCA1</i> - or <i>BRCA2</i> -Mutated Breast Cancer](https://scholariq.org/papers/adjuvant-olaparib-for-patients-with-i-brca1-i-or-i-brca2-i-mutated-breast-cancer/)
- [Olaparib Monotherapy in Patients With Advanced Cancer and a Germline <i>BRCA1/2</i> Mutation](https://scholariq.org/papers/olaparib-monotherapy-in-patients-with-advanced-cancer-and-a-germline-i-brca1-2-i/)
- [5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)](https://scholariq.org/papers/5th-eso-esmo-international-consensus-guidelines-for-advanced-breast-cancer-abc-5/)
- [4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)](https://scholariq.org/papers/4th-eso-esmo-international-consensus-guidelines-for-advanced-breast-cancer-abc-4/)
- [Interplay between BRCA1 and RHAMM Regulates Epithelial Apicobasal Polarization and May Influence Risk of Breast Cancer](https://scholariq.org/papers/interplay-between-brca1-and-rhamm-regulates-epithelial-apicobasal-polarization/)

## Researcher topics

- [BRCA gene mutations in cancer](https://scholariq.org/topics/brca-gene-mutations-in-cancer/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)

## Researcher university

- [NYU Langone Health](https://scholariq.org/institutions/nyu-langone-health/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.